Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
72.7 CHF | -0.82% | -1.09% | +42.83% |
Apr. 26 | Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024 | CI |
Apr. 25 | Cosmo Pharmaceuticals Names New CEO, Chairman | MT |
Sales 2023 | 96.72M 105M 95.61M | Sales 2024 * | 262M 283M 259M | Capitalization | 1.19B 1.28B 1.17B |
---|---|---|---|---|---|
Net income 2023 | 1M 1.08M 988K | Net income 2024 * | 111M 120M 110M | EV / Sales 2023 | 8.6 x |
Net cash position 2023 | 48.44M 52.34M 47.88M | Net cash position 2024 * | 110M 119M 109M | EV / Sales 2024 * | 4.12 x |
P/E ratio 2023 |
771
x | P/E ratio 2024 * |
10.2
x | Employees | 319 |
Yield 2023 |
3.65% | Yield 2024 * |
2.84% | Free-Float | 44.49% |
Latest transcript on Cosmo Pharmaceuticals N.V.
1 day | -0.82% | ||
1 week | -1.09% | ||
Current month | +0.55% | ||
1 month | -2.28% | ||
3 months | +10.32% | ||
6 months | +89.57% | ||
Current year | +42.83% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 61 | 05-12-31 | |
Niall Donnelly
DFI | Director of Finance/CFO | 52 | 16-05-31 |
Chief Tech/Sci/R&D Officer | 54 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David W Maris
BRD | Director/Board Member | 57 | 21-05-27 |
Founder | 69 | 96-12-31 | |
Director/Board Member | 64 | 05-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - | |
0.00% | 746 M€ | -.--% | - | |
0.00% | 34 M€ | +4.01% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 72.7 | -0.82% | 5 024 |
24-05-22 | 73.3 | +1.52% | 12,320 |
24-05-21 | 72.2 | -0.96% | 10,567 |
24-05-17 | 72.9 | -0.82% | 7,142 |
24-05-16 | 73.5 | -0.14% | 23,953 |
Delayed Quote Swiss Exchange, May 23, 2024 at 11:31 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.83% | 1.29B | |
+38.08% | 723B | |
+34.28% | 595B | |
-4.48% | 369B | |
+20.11% | 332B | |
+2.73% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
+0.03% | 168B |
- Stock Market
- Equities
- COPN Stock